secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0000950170-22-026261
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health and Reliefband mutually terminate acquisition agreement citing market conditions
--------------------------------------------------------------------------------

- Tivic Health and Reliefband Technologies mutually terminated the Asset Purchase Agreement on December 7, 2022.
- The deal was announced October 7, 2022; termination follows a review of financing alternatives amid volatile capital markets.
- CEO Jennifer Ernst said proceeding with the acquisition is not in the best interest of stakeholders at this time.
- Tivic will focus on accelerating ClearUP sales and expanding its organic product pipeline.
- Both parties remain on good terms despite disappointment; Tivic will continue to evaluate M&A and partnership opportunities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017022026261/0000950170-22-026261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017022026261/tivc-20221207.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer